Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Cancer Conference Journal|March 31, 2021
Renal allograft rejection after treatment with nivolumab in patients with metastatic renal cell carcinomaGaku Ishikawa, Takayuki Sugiyama, Toshiki Ito, et al.
Anticancer Research|June 29, 2026
Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell CarcinomaGaku Ishikawa, Keita Tamura, Kyohei Watanabe, et al.
International Journal of Clinical Oncology|October 30, 2024
Efficacy and safety of lenvatinib and pembrolizumab as first-line treatment for advanced renal cell carcinoma patients: real-world experience in JapanTakuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 23, 2025
Current Kidney-Preserving Strategies for Upper Tract Urothelial CarcinomaTeruo Inamoto, Shunsuke Watanabe, Yoshihiro Tsuchiya, et al.
Asian Journal of Endoscopic Surgery|June 4, 2025
Comparing Perioperative Outcomes Using Single and Multiple Robot Systems During the Learning Period for Robot-Assisted Radical ProstatectomyYuto Matsushita, Yoshihiro Tsuchiya, Gaku Ishikawa, et al.
Anticancer Research|December 31, 2024
Comparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell CarcinomaGaku Ishikawa, Keita Tamura, Yoshihiro Tsuchiya, et al.
Japanese Journal of Clinical Oncology|March 10, 2025
Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancerYuto Matsushita, Yoshihiro Tsuchiya, Gaku Ishikawa, et al.
Transplantation Proceedings|June 28, 2025
Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in JapanAsuka Sano, Takayuki Sugiyama, Shinsuke Isobe, et al.
Central European Journal of Urology|June 30, 2026
Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world studyShunsuke Watanabe, Yuichi Kitagawa, Asuka Uchiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2022
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumabRyo Sato, Teruo Inamoto, Yuto Matsushita, et al.
Pageof 2